stockrowPulse Biosciences, Inc
PLSE Healthcare Medical Instruments & Supplies
Pulse Biosciences, Inc’s revenue for fiscal 2025 (year ended December 2025) was $350,000.00, down 50.0% from fiscal 2022.
- Revenue
- +359.3%
- EPS
- −10.3%
- Free cash flow
- −1,180.5%
Quarter to September 2026, against a year earlier
Follow PLSE
Alert me
Pulse Biosciences, Inc (PLSE) Gross margin
Pulse Biosciences, Inc's gross margin over the twelve months to 30 September 2026 was 26.8%, up 80.8 percentage points from fiscal 2025 (−54.0%). Over the past ten years it has ranged from −1,606.3% (fiscal 2022) to 0.00% (fiscal 2020); the current reading is higher than 25% of that period. That is below the Medical Instruments & Supplies industry median of 53.6% and below the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | −54.0% | 1,552.29 |
| FY2022 | −1,606.3% | (1,567.50) |
| FY2021 | −38.8% | (38.79) |
| FY2020 | 0.00% | 0.00 |
| FY2019 | 0.00% | 0.00 |
| FY2018 | 0.00% | 0.00 |
| FY2017 | 0.00% | 0.00 |
| FY2016 | 0.00% | — |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 51.7% | 14.55 |
| Jun 2026 | 37.1% | 29.37 |
| Mar 2026 | 7.73% | 6.21 |
| Dec 2025 | 1.52% | 225.94 |
| 17 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| ATRC AtriCure, Inc. compare | 76.7% |
| NVST Envista Holdings Corporation compare | 55.9% |
| TFX Teleflex Incorporated compare | 54.9% |
| WRBY Warby Parker Inc. compare | 54.8% |
| MMED MiniMed Group, Inc. compare | 53.6% |
| MMSI Merit Medical Systems, Inc. compare | 49.4% |
| ICUI ICU Medical, Inc. compare | 40.3% |
| STVN Stevanato Group S.p.A. compare | 29.1% |
| PLSE Pulse Biosciences, Inc | 26.8% |
| Medical Instruments & Supplies industry median | 53.6% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on PLSE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Altman Z-score
- The full statement